RARA and cancer: Among the list of co-expressed features of interest, both RARA (retinoic acid receptor alpha) and RXRA (retinoid X receptor alpha) are identified as strong negative correlates, whereas ZNF207, an early developmental factor linked with pluripotency factors [33], is a strong positive correlate in cancer (Figure 1f).